About Liver360

Liver360 Learning Platform

Bayer’s Liver360 learning platform supports improvements in liver disease outcomes by providing educational resources to support liver disease management.

Worldwide, liver cancer is the 6th most common form of cancer. In 2020 alone, more than 900,000 new cases were diagnosed. The disease burden in Asia is particularly high, with an astounding incidence rate of 72.5%*1

To improve liver disease outcomes, imaging strategies that result in patients receiving early detection, an accurate diagnosis, and optimal treatment are essential.

Liver 360 is a growing database offering practical content shared by our network of doctors in Asia designed to develop your knowledge and skills.  

Together, we can better understand liver diseases by harnessing our collective knowledge.

  • *1.Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10th Oct 2022.